Lenalidomid BMS 5 mg, Hartkapseln - 21 Swissmedic Key 68490002 CM Registration Holder Bristol-Myers Squibb SA Name Lenalidomid BMS 5 mg, Hartkapseln Date of registration 14.06.2021 Original/Generic Generic Introduction of Sequence 14.06.2021 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 21 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 707.76 Limitation Yes Limitation text
Deductible 10 % Consumer price 786.15 Feedback FB Daily cost GTIN 7680684900020 Medication Code Synthetika Pharmacode Disponibility
Composition lenalidomidum 5 mg, lactosum 147 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.4 mg, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 5 mg
BAG: Active Agent Dose Lenalidomidum 5 mg
Inactive agents Dose additional_information (Nigrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Lactosum 147 mg Magnesii Stearas Pro Capsula Propylenglycol
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
